Politics, pharma, patent, profit or the people of India? A case for compulsory licensing – Bar & Bench – Indian Legal News
Politics, pharma, patent, profit or the people of India? A case for compulsory licensing Bar & Bench – Indian Legal News
In: PATENT NEWS
Politics, pharma, patent, profit or the people of India? A case for compulsory licensing Bar & Bench – Indian Legal News
In: PATENT NEWS
… States is being pushed to join a scheme to persuade all manufacturers of Covid-19 vaccines worldwide to give up their intellectual property rights.
In: PATENT NEWS
COVID vaccine makers must relent on intellectual property rights and see to the world’s needs. Updated May 1, 2021, 30 minutes ago. In this March 5 …
http://www.epo.org/service-support/availability-of-online-services/2021/20210430.html Content reproduced from the Website of the European Patent Office as permitted by their terms of use. Technical fault in the EPO’s credit card fee payment and refund claim service (Ref. 1341756) We have been informed that since 29 April 2021 some users have been experiencing problems when paying fees... Continue reading
In: TRADEMARK NEWS
WWE Files Trademark For ‘Top Dolla’ Heel By Nature
In: TRADEMARK NEWS
Top 10 differences between Canadian and U.S. trademark filing, prosecution and enforcement JD Supra
In: COPYRIGHT NEWS
Copyright reform in Singapore continues release of draft Bill for public consultation JD Supra
In: PATENT NEWS
Top Drugs Losing Patent Exclusivity in 2021 | McDonnell Boehnen Hulbert & Berghoff LLP – JDSupra JD Supra
http://www.epo.org/law-practice/legal-texts/official-journal/2021/04.html Content reproduced from the Website of the European Patent Office as permitted by their terms of use. Official Journal April 2021 2021 | 4 – April | Next | Previous | Year 44, number 4, articles A29-A37 Download certified PDF SHA-1: abfe88204f014f14468cfeb23c8803d18fd45f75 Official Journal April 2021 loading … Article Article... Continue reading
In: PATENT NEWS
To the kingdom, this means the green light for the GPO to produce the medicine for local use. Yet, under the patent law, the Japanese pharmaceutical …
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION